Ivermectin News and Research

RSS

Ivermectin (22,23-dihydroavermectin B1a + 22,23-dihydroavermectin B1b) is a broad-spectrum antiparasitic medication. It is traditionally used against worms, but more recently found to be effective against mites and some lice too. Ivermectin is currently being used to help eliminate river blindness (onchocerciasis) in the Americas and stop transmission of lymphatic filariasis around the world.

What natural compounds can help you manage your rosacea?

Researchers reviewed existing data on rosacea management using botanicals.

7 Feb 2024

How fringe anti-science views infiltrated mainstream politics — and what it means in 2024

Rates of routine childhood vaccination hit a 10-year low in 2023. That, according to the Centers for Disease Control and Prevention, puts about 250,000 kindergartners at risk for measles, which often leads to hospitalization and can cause death.

29 Jan 2024

KFF Health News' 'What the Health?': 2023 is a wrap

Even without covid dominating the headlines, 2023 was a busy year for health policy.

21 Dec 2023

WHO experts update guidance on COVID-19 treatments

A panel of international experts representing the World Health Organization's Guideline Development Group has updated its guidance on treatments for patients with covid-19.

9 Nov 2023

New analysis of Indonesia Wolbachia trial shows potential for greater dengue reduction

The fight against dengue fever has a new weapon: a mosquito infected with the bacteria Wolbachia, which prevents the spread of the virus.

6 Nov 2023

Few firm beliefs and low trust: Americans not sure what’s true in age of health misinformation

Around 3 in 10 Americans still believe ivermectin is an effective treatment for covid. What's more, few place significant trust in any form of news media or official institution to accurately convey information about health topics, from covid treatments and vaccines to reproductive health issues, a new poll from KFF shows.

22 Aug 2023

COVID-19 misinformation spread on social media by US physicians

The harm caused by coronavirus disease 2019 (COVID-19) misinformation.

18 Aug 2023

FDA head Robert Califf battles misinformation — sometimes with fuzzy facts

Robert Califf, the head of the Food and Drug Administration, doesn't seem to be having fun on the job.

24 Jul 2023

How a combination of covid lawsuits and media coverage keeps misinformation churning

Public health has had its day in court lately. And another day. And another day.

14 Jul 2023

Metformin shows promising antiviral activity against SARS-CoV-2

Metformin, a widely available oral medication, reduces SARS-CoV-2 viral load by 3.6-fold in outpatient trial, offering a potential treatment option. Ivermectin and fluvoxamine show no significant virologic effect.

12 Jun 2023

Metformin reduces risk of long COVID by over 40%

Researchers discuss whether metformin, ivermectin, or fluvoxamine could reduce the risk of long COVID if administered shortly after infection.

12 Jun 2023

Common diabetes drug prevents the development of long COVID, study finds

In a new study published in The Lancet Infectious Diseases, University of Minnesota researchers found that metformin, a drug commonly used to treat diabetes, prevents the development of long COVID.

9 Jun 2023

Do COVID-19 drugs in aquatic matrices negatively impact microalgae and cyanobacteria communities?

Researchers evaluated the presence of coronavirus disease 2019 (COVID-19) drugs in river water.

8 Jun 2023

Anticoronavirals: the development of COVID-19 therapies and the challenges that remain

Researchers highlighted the pace of development of COVID-19 therapies during the pandemic and the challenges that hinder the widespread availability of anticoronavirals.

8 May 2023

The policy, and politics, of Medicare Advantage

Medicare Advantage, the private-sector alternative to original Medicare, now enrolls nearly half of all Medicare beneficiaries.

23 Mar 2023

Early outpatient treatment of COVID-19 with metformin could reduce the risk of developing long COVID

In a recent study posted to Preprints with The Lancet*, a team of researchers from the United States investigated whether early outpatient treatment of coronavirus disease 2019 (COVID-19) patients with fluvoxamine, ivermectin, or metformin could prevent long coronavirus disease (long COVID).

9 Mar 2023

Ivermectin News and Research

What natural compounds can help you manage your rosacea?

How fringe anti-science views infiltrated mainstream politics — and what it means in 2024

KFF Health News' 'What the Health?': 2023 is a wrap

WHO experts update guidance on COVID-19 treatments

New analysis of Indonesia Wolbachia trial shows potential for greater dengue reduction

Few firm beliefs and low trust: Americans not sure what’s true in age of health misinformation

COVID-19 misinformation spread on social media by US physicians

FDA head Robert Califf battles misinformation — sometimes with fuzzy facts

How a combination of covid lawsuits and media coverage keeps misinformation churning

Metformin shows promising antiviral activity against SARS-CoV-2

Metformin reduces risk of long COVID by over 40%

Common diabetes drug prevents the development of long COVID, study finds

Do COVID-19 drugs in aquatic matrices negatively impact microalgae and cyanobacteria communities?

Anticoronavirals: the development of COVID-19 therapies and the challenges that remain

The policy, and politics, of Medicare Advantage

Early outpatient treatment of COVID-19 with metformin could reduce the risk of developing long COVID

High-dose ivermectin does not reduce COVID-19 symptom duration among mild-to-moderate outpatients

Senators have mental health crises, too

What are the predictors of in-hospital mortality in cancer patients with COVID-19?

The efficacy of low-dose fluvoxamine compared with placebo for treating mild to moderate COVID-19 in the US

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News